Sumitomo Seika Chemicals Co., Ltd. (JP:4008)
:4008
Want to see JP:4008 full AI Analyst Report?
Top Page
Sumitomo Seika Chemicals Co., Ltd.
(4008)
Select Model
Select Model
Rating:70Outperform
Price Target:
¥1,372.00
▼(-74.59% Downside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by solid financial fundamentals (notably low leverage and improved 2026 profitability) and supportive valuation (low P/E and strong dividend yield). These positives are tempered by cash-flow volatility and weaker near-term technical momentum (negative MACD and sub-50 RSI).
Positive Factors
Balance Sheet Strength
Consistently low leverage and rising equity/assets provide durable financial flexibility. This strengthens the company’s ability to fund capex, manage cyclical downturns, and support dividends or strategic M&A without relying excessively on volatile external financing.
Negative Factors
Free Cash Flow Volatility
Uneven free cash flow and weak conversion of net income to FCF make capital returns and reinvestment planning less predictable. Persistent volatility in working capital or capex can constrain dividends, debt reduction or strategic investment over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Consistently low leverage and rising equity/assets provide durable financial flexibility. This strengthens the company’s ability to fund capex, manage cyclical downturns, and support dividends or strategic M&A without relying excessively on volatile external financing.
Read all positive factors
Sumitomo Seika Chemicals Co., Ltd. (4008) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥82.69B
Dividend Yield3.74%
Average Volume (3M)41.43K
Price to Earnings (P/E)10.1
Beta (1Y)0.77
Revenue Growth0.53%
EPS Growth30.98%
CountryJP
Employees1,402
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)67.73
Shares Outstanding64,683,784
10 Day Avg. Volume33,250
30 Day Avg. Volume41,433
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)0.75
Price to Sales (P/S)0.52
P/FCF Ratio15.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sumitomo Seika Chemicals Co., Ltd. Business Overview & Revenue Model
Company Description
Sumitomo Seika Chemicals Company, Limited manufactures and sells absorbent polymers, functional chemicals, and gases in Japan and internationally. The company offers sodium polyacrylate-based super absorbent polymer for use in hygiene products, in...
How the Company Makes Money
null...
Sumitomo Seika Chemicals Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
84
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.24B | 148.35B | 147.57B | 142.99B | 143.04B | 115.58B |
| Gross Profit | 30.38B | 35.44B | 30.39B | 27.72B | 29.93B | 26.00B |
| EBITDA | 15.62B | 19.99B | 16.45B | 15.28B | 15.55B | 12.97B |
| Net Income | 4.49B | 7.68B | 5.96B | 6.17B | 8.59B | 5.90B |
Balance Sheet | ||||||
| Total Assets | 141.32B | 152.73B | 141.53B | 136.31B | 126.65B | 121.27B |
| Cash, Cash Equivalents and Short-Term Investments | 18.93B | 18.22B | 16.86B | 21.66B | 23.55B | 29.25B |
| Total Debt | 22.29B | 17.93B | 18.86B | 11.57B | 12.62B | 14.55B |
| Total Liabilities | 47.05B | 49.11B | 47.22B | 41.25B | 39.99B | 39.37B |
| Stockholders Equity | 94.26B | 103.62B | 94.31B | 95.05B | 86.66B | 78.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.09B | -5.98B | 3.80B | 1.80B | 5.39B |
| Operating Cash Flow | 0.00 | 17.48B | 13.68B | 12.01B | 6.70B | 9.02B |
| Investing Cash Flow | 0.00 | -11.33B | -20.91B | -10.37B | -9.61B | -4.32B |
| Financing Cash Flow | 0.00 | -5.09B | 3.19B | -5.77B | -4.63B | -2.99B |
Sumitomo Seika Chemicals Co., Ltd. Technical Analysis
Positive
5400.00
Price Trends
1242.13
Positive
1205.50
Positive
1074.74
Positive
Market Momentum
9.52
Negative
58.20
Neutral
86.49
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4008, the sentiment is Positive. The current price of 5400 is above the 20-day moving average (MA) of 1227.25, above the 50-day MA of 1242.13, and above the 200-day MA of 1074.74, indicating a bullish trend. The MACD of 9.52 indicates Negative momentum. The RSI at 58.20 is Neutral, neither overbought nor oversold. The STOCH value of 86.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4008.
Sumitomo Seika Chemicals Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥321.20B | 9.57 | 5.47% | 3.41% | 0.55% | 25.37% | |
70 Outperform | ¥82.69B | 10.06 | ― | 3.74% | 0.53% | 30.98% | |
67 Neutral | ¥296.35B | 9.89 | 1.47% | 4.29% | -5.02% | ― | |
63 Neutral | ¥351.92B | 12.11 | 9.45% | 2.65% | 1.87% | -5.06% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥868.75B | 20.28 | 2.01% | 3.82% | -7.76% | 7.92% | |
58 Neutral | ¥1.05T | -17.36 | -2.50% | 3.49% | -4.57% | -190.44% |
* Basic Materials Sector Average
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
1,319.00
451.69
52.08%
JP:4118
Kaneka
5,338.00
1,572.73
41.77%
JP:4182
Mitsubishi Gas Chemical Company
5,401.00
3,318.80
159.39%
JP:4183
Mitsui Chemicals
2,204.00
702.41
46.78%
JP:4043
Tokuyama
4,929.00
2,207.94
81.14%
JP:4208
UBE Industries
2,975.50
832.24
38.83%
Sumitomo Seika Chemicals Co., Ltd. Corporate Events
Sumitomo Seika Announces Share Buyback and Subsequent Cancellation
May 12, 2026
Sumitomo Seika Chemicals has approved a share buyback of up to 840,000 shares, representing about 1.3% of its outstanding stock, with a maximum outlay of 1 billion yen via market purchases on the Tokyo Stock Exchange between May 13 and September 3...
Sumitomo Seika Chemicals to Cancel 7.5% of Outstanding Shares
May 12, 2026
Sumitomo Seika Chemicals has resolved to cancel 5,275,195 shares of its common stock, equivalent to 7.54% of its issued shares before cancellation. The move, approved by the Board of Directors under Article 178 of the Companies Act, will reduce th...
Sumitomo Seika Chemicals Revamps Board with New Independent Directors
May 12, 2026
Sumitomo Seika Chemicals has announced changes to its Board of Directors, to be formalized at the 113th Ordinary General Meeting of Shareholders on June 29, 2026. The company will reappoint five existing directors and newly appoint Yoshiyuki Tanak...
Sumitomo Seika Stresses Operational Independence From Major Shareholder Sumitomo Chemical
May 12, 2026
Sumitomo Seika Chemicals has disclosed details of its relationship with Sumitomo Chemical, which holds 33.4% of its voting rights and is classified as an other affiliated company. The firm emphasizes that no directors hold concurrent posts at both...
Sumitomo Seika Discloses Delayed Dividend Receipts From Overseas Subsidiaries
May 12, 2026
Sumitomo Seika Chemicals has disclosed that it received surplus dividends from key consolidated subsidiaries in China and South Korea over fiscal 2024 and 2025, totaling several billion yen. The company acknowledged a delay in making this disclosu...
Sumitomo Seika Profit Surges on Subsidiary Dividends Despite Modest Sales Growth
May 12, 2026
Sumitomo Seika Chemicals reported that its non-consolidated net sales for fiscal 2025 rose modestly year on year, while operating profit, ordinary profit, and net income posted much stronger gains. The company also implemented a stock split effect...
Sumitomo Seika Profit Jumps but Geopolitical Risks Cloud Outlook
May 12, 2026
Sumitomo Seika Chemicals reported a modest 0.5% rise in net sales to ¥148.4 billion for the fiscal year ended March 31, 2026, but delivered a sharp earnings rebound, with operating profit up 35.0% and profit attributable to owners of the pare...
Sumitomo Seika Completes Near-Full ¥1 Billion Share Buyback Program
Mar 25, 2026
Sumitomo Seika Chemicals announced that it has completed a share buyback program authorized by its Board of Directors in November 2025, acquiring 30,700 shares of its common stock between March 1 and March 24, 2026 for a total of ¥204.3 milli...
Sumitomo Seika Advances Share Buyback, Reaching Over Two-Thirds of Authorized Amount
Mar 3, 2026
Sumitomo Seika Chemicals has reported the latest progress of its share buyback program authorized by its board in November 2025. Between February 1 and February 28, 2026, the company repurchased 35,100 of its own common shares on the Tokyo Stock E...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.